Global Transcatheter Aortic Valve Replacement (TAVR) Market Growth (Status and Outlook) 2025-2031

Global Transcatheter Aortic Valve Replacement (TAVR) Market Growth (Status and Outlook) 2025-2031

The global Transcatheter Aortic Valve Replacement (TAVR) market size is predicted to grow from US$ 8580 million in 2025 to US$ 16220 million in 2031; it is expected to grow at a CAGR of 11.2% from 2025 to 2031.

Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.

The Transcatheter Aortic Valve Replacement (TAVR) market is primarily driven by the increasing prevalence of aortic stenosis and the growing aging population worldwide. As people live longer, the incidence of age-related cardiovascular conditions, such as aortic valve disease, is on the rise. TAVR offers a minimally invasive alternative to traditional open-heart surgery, making it a highly attractive option for elderly patients or those with high surgical risk. Additionally, technological advancements in TAVR devices, such as improved valve designs, delivery systems, and procedural techniques, have contributed to enhanced patient outcomes and safety, further expanding the market. The increasing acceptance of TAVR as a first-line treatment, even for intermediate-risk patients, also fuels market growth.

However, the TAVR market faces several challenges, primarily the high cost of the procedure and devices. Despite its advantages, TAVR is still a relatively expensive treatment, which can limit its accessibility, particularly in low- and middle-income countries or healthcare systems with constrained budgets. Furthermore, the long-term durability of TAVR valves remains a concern for both physicians and patients, as the procedure is relatively new compared to traditional surgical valve replacements. Ongoing research and clinical trials are needed to better understand the long-term outcomes of TAVR, which could influence its adoption and cost-effectiveness in the future.

Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Meril Life Sciences, etc. are the leaders of the industry, Top 5 compnay market share are about 90%

LPI (LP Information)' newest research report, the “Transcatheter Aortic Valve Replacement (TAVR) Industry Forecast” looks at past sales and reviews total world Transcatheter Aortic Valve Replacement (TAVR) sales in 2024, providing a comprehensive analysis by region and market sector of projected Transcatheter Aortic Valve Replacement (TAVR) sales for 2025 through 2031. With Transcatheter Aortic Valve Replacement (TAVR) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transcatheter Aortic Valve Replacement (TAVR) industry.

This Insight Report provides a comprehensive analysis of the global Transcatheter Aortic Valve Replacement (TAVR) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Transcatheter Aortic Valve Replacement (TAVR) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Transcatheter Aortic Valve Replacement (TAVR) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transcatheter Aortic Valve Replacement (TAVR) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transcatheter Aortic Valve Replacement (TAVR).

This report presents a comprehensive overview, market shares, and growth opportunities of Transcatheter Aortic Valve Replacement (TAVR) market by product type, application, key players and key regions and countries.

Segmentation by Type:
Transfemoral Approach
Transapical Approach
Others

Segmentation by Application:
Aortic Stenosis
Aortic Regurgitation
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific
Meril Life Sciences
Venus Medtech
Bracco (HLT)
JenaValve Technology
Suzhou Jiecheng Medical Technology Co.
Peijia Medical
MicroPort

Please note: The report will take approximately 2 business days to prepare and deliver.